|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 19584 |
FusionGeneSummary for LDLR_ABAT |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: LDLR_ABAT | Fusion gene ID: 19584 | Hgene | Tgene | Gene symbol | LDLR | ABAT | Gene ID | 3949 | 18 |
| Gene name | low density lipoprotein receptor | 4-aminobutyrate aminotransferase | |
| Synonyms | FH|FHC|LDLCQ2 | GABA-AT|GABAT|NPD009 | |
| Cytomap | 19p13.2 | 16p13.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | low-density lipoprotein receptorLDL receptorlow-density lipoprotein receptor class A domain-containing protein 3 | 4-aminobutyrate aminotransferase, mitochondrial(S)-3-amino-2-methylpropionate transaminase4-aminobutyrate transaminaseGABA aminotransferaseGABA transaminaseGABA transferasegamma-amino-N-butyrate transaminase | |
| Modification date | 20180520 | 20180523 | |
| UniProtAcc | P01130 | P80404 | |
| Ensembl transtripts involved in fusion gene | ENST00000558518, ENST00000557933, ENST00000455727, ENST00000535915, ENST00000545707, ENST00000558013, ENST00000560628, | ENST00000268251, ENST00000396600, ENST00000563215, ENST00000567812, ENST00000425191, ENST00000569156, | |
| Fusion gene scores | * DoF score | 14 X 9 X 11=1386 | 6 X 6 X 4=144 |
| # samples | 17 | 6 | |
| ** MAII score | log2(17/1386*10)=-3.02732060599951 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(6/144*10)=-1.26303440583379 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: LDLR [Title/Abstract] AND ABAT [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | AA002171 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3UTR | ENST00000558518 | ENST00000268251 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-3UTR | ENST00000558518 | ENST00000396600 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-intron | ENST00000558518 | ENST00000563215 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-intron | ENST00000558518 | ENST00000567812 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-intron | ENST00000558518 | ENST00000425191 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-intron | ENST00000558518 | ENST00000569156 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-3UTR | ENST00000557933 | ENST00000268251 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-3UTR | ENST00000557933 | ENST00000396600 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-intron | ENST00000557933 | ENST00000563215 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-intron | ENST00000557933 | ENST00000567812 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-intron | ENST00000557933 | ENST00000425191 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-intron | ENST00000557933 | ENST00000569156 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-3UTR | ENST00000455727 | ENST00000268251 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-3UTR | ENST00000455727 | ENST00000396600 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-intron | ENST00000455727 | ENST00000563215 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-intron | ENST00000455727 | ENST00000567812 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-intron | ENST00000455727 | ENST00000425191 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-intron | ENST00000455727 | ENST00000569156 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-3UTR | ENST00000535915 | ENST00000268251 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-3UTR | ENST00000535915 | ENST00000396600 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-intron | ENST00000535915 | ENST00000563215 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-intron | ENST00000535915 | ENST00000567812 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-intron | ENST00000535915 | ENST00000425191 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-intron | ENST00000535915 | ENST00000569156 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-3UTR | ENST00000545707 | ENST00000268251 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-3UTR | ENST00000545707 | ENST00000396600 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-intron | ENST00000545707 | ENST00000563215 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-intron | ENST00000545707 | ENST00000567812 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-intron | ENST00000545707 | ENST00000425191 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-intron | ENST00000545707 | ENST00000569156 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-3UTR | ENST00000558013 | ENST00000268251 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-3UTR | ENST00000558013 | ENST00000396600 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-intron | ENST00000558013 | ENST00000563215 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-intron | ENST00000558013 | ENST00000567812 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-intron | ENST00000558013 | ENST00000425191 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-intron | ENST00000558013 | ENST00000569156 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-3UTR | ENST00000560628 | ENST00000268251 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-3UTR | ENST00000560628 | ENST00000396600 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-intron | ENST00000560628 | ENST00000563215 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-intron | ENST00000560628 | ENST00000567812 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-intron | ENST00000560628 | ENST00000425191 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
| intron-intron | ENST00000560628 | ENST00000569156 | LDLR | chr19 | 11244309 | - | ABAT | chr16 | 8877972 | - |
Top |
FusionProtFeatures for LDLR_ABAT |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| LDLR | ABAT |
| Catalyzes the conversion of gamma-aminobutyrate and L-beta-aminoisobutyrate to succinate semialdehyde and methylmalonatesemialdehyde, respectively. Can also convert delta-aminovalerateand beta-alanine. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for LDLR_ABAT |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for LDLR_ABAT |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for LDLR_ABAT |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Hgene | LDLR | P01130 | DB00707 | Porfimer sodium | Low-density lipoprotein receptor | small molecule | approved|investigational |
| Tgene | ABAT | P80404 | DB00780 | Phenelzine | 4-aminobutyrate aminotransferase, mitochondrial | small molecule | approved |
| Tgene | ABAT | P80404 | DB01080 | Vigabatrin | 4-aminobutyrate aminotransferase, mitochondrial | small molecule | approved |
| Tgene | ABAT | P80404 | DB00313 | Valproic Acid | 4-aminobutyrate aminotransferase, mitochondrial | small molecule | approved|investigational |
| Tgene | ABAT | P80404 | DB00114 | Pyridoxal Phosphate | 4-aminobutyrate aminotransferase, mitochondrial | small molecule | approved|investigational|nutraceutical |
| Tgene | ABAT | P80404 | DB00142 | Glutamic Acid | 4-aminobutyrate aminotransferase, mitochondrial | small molecule | approved|nutraceutical |
Top |
RelatedDiseases for LDLR_ABAT |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | LDLR | C0745103 | Hyperlipoproteinemia Type IIa | 32 | CTD_human;ORPHANET;UNIPROT |
| Hgene | LDLR | C0020445 | Hypercholesterolemia, Familial | 6 | CTD_human;HPO |
| Hgene | LDLR | C0004153 | Atherosclerosis | 4 | CTD_human |
| Hgene | LDLR | C0020443 | Hypercholesterolemia | 4 | CTD_human;HPO |
| Hgene | LDLR | C0400966 | Non-alcoholic Fatty Liver Disease | 3 | CTD_human |
| Hgene | LDLR | C0020473 | Hyperlipidemia | 2 | CTD_human;HPO |
| Hgene | LDLR | C1956346 | Coronary Artery Disease | 2 | CTD_human |
| Hgene | LDLR | C0010068 | Coronary heart disease | 1 | CTD_human |
| Hgene | LDLR | C0015695 | Fatty Liver | 1 | CTD_human |
| Hgene | LDLR | C0020507 | Hyperplasia | 1 | CTD_human |
| Hgene | LDLR | C0028754 | Obesity | 1 | CTD_human |
| Hgene | LDLR | C0034362 | Q Fever | 1 | CTD_human |
| Hgene | LDLR | C0085762 | Alcohol abuse | 1 | PSYGENET |
| Hgene | LDLR | C0242339 | Dyslipidemias | 1 | CTD_human |
| Hgene | LDLR | C1862939 | AMYOTROPHIC LATERAL SCLEROSIS 1 | 1 | CTD_human |
| Tgene | ABAT | C0004352 | Autistic Disorder | 1 | CTD_human |
| Tgene | ABAT | C0017168 | Gastroesophageal reflux disease | 1 | CTD_human |
| Tgene | ABAT | C0023380 | Lethargy | 1 | CTD_human;HPO |
| Tgene | ABAT | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
| Tgene | ABAT | C0026827 | Muscle hypotonia | 1 | CTD_human |
| Tgene | ABAT | C0033922 | Psychomotor Disorders | 1 | CTD_human |
| Tgene | ABAT | C0034933 | Reflex, Abnormal | 1 | CTD_human |
| Tgene | ABAT | C0036572 | Seizures | 1 | CTD_human;HPO |
| Tgene | ABAT | C0342708 | Gamma aminobutyric acid transaminase deficiency | 1 | CTD_human;ORPHANET;UNIPROT |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|